A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris
| Status: | Completed |
|---|---|
| Conditions: | Acne, Acne, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 12 - Any |
| Updated: | 10/10/2018 |
| Start Date: | November 2013 |
| End Date: | October 2014 |
A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients With Acne Vulgaris
This study will assess the safety and efficacy of dapsone gel versus vehicle control in
patients with acne vulgaris.
patients with acne vulgaris.
This is a multicenter, double-blind, randomized, parallel-group, vehicle-controlled study to
assess the safety and efficacy of dapsone 7.5% gel versus vehicle administered topically once
daily for 12 weeks in patients with acne vulgaris.
assess the safety and efficacy of dapsone 7.5% gel versus vehicle administered topically once
daily for 12 weeks in patients with acne vulgaris.
Inclusion Criteria:
- Diagnosis of acne vulgaris
- Willing to avoid excessive or prolonged exposure to ultraviolet light (eg, sunlight,
tanning beds) throughout the study
Exclusion Criteria:
- Severe cystic acne, acne conglobata, acne fulminans, or secondary acne
- Use of phototherapy devices (eg, ClearLight™), energy-based devices, adhesive
cleansing strips (eg, Pond's®, Biore®), or cosmetic procedures (eg, facials, peeling,
comedo extraction) in the past week
- Use of anti-inflammatory medications, salicylic acid; corticosteroids, antibiotics,
antibacterials (including benzoyl peroxide-containing products [eg, benzamycin]),
retinoids; other topical acne treatments (eg, photodynamic therapy, medicated soaps
such as those containing benzoyl peroxide, salicylic acid, sulfur, or sodium
sulfacetamide) in the past 2 weeks
- Use of birth control pills strictly for acne control
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials